Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage

Inclusion Criteria: * women who underwent spontaneous vaginal delivery with Post partum hemorrhage (PPH) ≥ 500ml OR women who underwent lower segment caesarean section with PPH ≥ 1000 ml * post PPH haemoglobin level ≤ 10.0 g/dl measured within 48hrs after delivery and stabilisation \& resuscitation. * ≥ 18 years of age * Proficient in Malaysian language or English language * Willingness to consent for blood taking and attending follow-up at 2 weeks and 6 weeks Exclusion Criteria: * refused consent to participate in trial * history of hemolytic anemia, Thalassemia , and sickle cell anemia * women with signs of sepsis (clinical or laboratory evidence-intrapartum fever \>38.5 degrees with abnormal vital signs, positive blood culture) * clinical or laboratory evidence of hepatic or renal, cardiovascular and hemolytic abnormalities * history of active severe acid peptic disorder, esophagitis or hiatus hernia and malabsorption syndrome. * Severe symptoms of anemia including dyspnoea at rest, angina pectoris, syncope or transient ischemic attacks. * history of severe asthma, eczema or other atopic allergy * known allergy to iron * patients with known immune or inflammatory conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis).